Alliance Pharmaceuticals

Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
Telephone: +44 (0)1249 466 966
Fax: +44 (0)1249 466 977
WWW: http://www.alliancepharma.co.uk
Medical Information e-mail: medinfo@alliancepharma.co.uk

Summary of Product Characteristics last updated on the eMC: 15/08/2011
SPC Anbesol Liquid

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change of Marketing Authorisation Holder
Date of revision of text on the SPC:   21-Jul-2011
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Following an acquisition the MAH is now Alliance

7          MARKETING AUTHORISATION HOLDER

 

Alliance Pharmaceuticals Limited

Avonbridge House

Bath Road

Chippenham

Wiltshire

SN15 2BB

UK

 

 

8          MARKETING AUTHORISATION NUMBER

 

PL 16853/0128

Updated on 28/09/2006 and displayed until 15/08/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 27/09/2006 and displayed until 28/09/2006
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   08/2006
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 7 - Change to MA holder
Section 8 - Change to MA number in line with above
Section 9 - Date of grant in line with above
Section 10 - Change to text in line will all of above changes
Updated on 16/09/2003 and displayed until 27/09/2006
Reasons for adding or updating:
  • Change to section 9 - Date of Renewal of Authorisation
Updated on 03/07/2001 and displayed until 16/09/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 28/03/2001 and displayed until 03/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   lidocaine hydrochloride
   chlorocresol
   cetylpyridinium chloride